The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-01-05
DOI
10.1038/srep18652
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers
- (2015) S T Kundu et al. ONCOGENE
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion
- (2014) C. P. Bracken et al. EMBO JOURNAL
- ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism
- (2014) Yanan Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression
- (2014) Janna K Mouw et al. NATURE MEDICINE
- A pan-cancer proteomic perspective on The Cancer Genome Atlas
- (2014) Rehan Akbani et al. Nature Communications
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways
- (2013) X Li et al. ONCOGENE
- The role of epithelial–mesenchymal transition programming in invasion and metastasis: a clinical perspective
- (2013) Chad Creighton et al. Cancer Management and Research
- A Synthetic Matrix with Independently Tunable Biochemistry and Mechanical Properties to Study Epithelial Morphogenesis and EMT in a Lung Adenocarcinoma Model
- (2012) B. J. Gill et al. CANCER RESEARCH
- ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression
- (2012) Young-Ho Ahn et al. JOURNAL OF CLINICAL INVESTIGATION
- Overexpression of crkl correlates with poor prognosis and cell proliferation in non-small cell lung cancer
- (2012) Yan Wang et al. MOLECULAR CARCINOGENESIS
- CrkL is not Crk-like
- (2012) Yoshihiro Kobashigawa et al. Nature Chemical Biology
- Targets of the Tumor Suppressor miR-200 in Regulation of the Epithelial-Mesenchymal Transition in Cancer
- (2011) M. J. Schliekelman et al. CANCER RESEARCH
- MicroRNAs as regulators of epithelial-mesenchymal transition
- (2011) Philip A. Gregory et al. CELL CYCLE
- The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200–dependent pathway in mice
- (2011) Yanan Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanisms by Which the Extracellular Matrix and Integrin Signaling Act to Regulate the Switch Between Tumor Suppression and Tumor Promotion
- (2011) Patricia J. Keely JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- MicroRNA-200c Represses Migration and Invasion of Breast Cancer Cells by Targeting Actin-Regulatory Proteins FHOD1 and PPM1F
- (2011) S. Jurmeister et al. MOLECULAR AND CELLULAR BIOLOGY
- Amplification of CRKL Induces Transformation and Epidermal Growth Factor Receptor Inhibitor Resistance in Human Non-Small Cell Lung Cancers
- (2011) H. W. Cheung et al. Cancer Discovery
- MicroRNAs in malignant progression
- (2010) Li Ma et al. CELL CYCLE
- Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer
- (2010) P. Ceppi et al. MOLECULAR CANCER RESEARCH
- Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
- (2009) Yohei Shimono et al. CELL
- Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression
- (2009) D. L. Gibbons et al. GENES & DEVELOPMENT
- A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
- (2009) Xiaoxia Hu et al. GYNECOLOGIC ONCOLOGY
- Down-regulation of miR-141 in gastric cancer and its involvement in cell growth
- (2009) Ying Du et al. JOURNAL OF GASTROENTEROLOGY
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer
- (2009) Y H Kim et al. ONCOGENE
- Expression Signatures of Metastatic Capacity in a Genetic Mouse Model of Lung Adenocarcinoma
- (2009) Don L. Gibbons et al. PLoS One
- A Double-Negative Feedback Loop between ZEB1-SIP1 and the microRNA-200 Family Regulates Epithelial-Mesenchymal Transition
- (2008) C. P. Bracken et al. CANCER RESEARCH
- A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
- (2008) Ulrike Burk et al. EMBO REPORTS
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2
- (2008) Manav Korpal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Phosphatidylinositol 3-Kinase Mediates Bronchioalveolar Stem Cell Expansion in Mouse Models of Oncogenic K-ras-Induced Lung Cancer
- (2008) Yanan Yang et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search